NCH57 is a patient-derived gliosarcoma cell line established from a primary WHO grade IV tumour resected from a 60 year old male patient. Gliosarcoma represents a rare variant of glioblastoma. Cells grow as adherent monolayer cultures under standard conditions.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.